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Abstract Bronchopulmonary dysplasia (BPD) is the most
common complication of preterm birth, with appreciable mor-
bidity and mortality in a neonatal intensive care setting. Much
interest has been shown in the identification of pathogenic
pathways that are amenable to pharmacological manipulation
(1) to facilitate the development of novel therapeutic and med-
ical management strategies and (2) to identify the basic mech-
anisms of late lung development, which remains poorly un-
derstood. A number of animal models have therefore been
developed and continue to be refined with the aim of recapit-
ulating pathological pulmonary hallmarks noted in lungs from
neonates with BPD. These animal models rely on several in-
jurious stimuli, such as mechanical ventilation or oxygen tox-
icity and infection and sterile inflammation, as applied in
mice, rats, rabbits, pigs, lambs and nonhuman primates. This
review addresses recent developments in modeling BPD in
experimental animals and highlights important neglected
areas that demand attention. Additionally, recent progress in
the quantitative microscopic analysis of pathology tissue is
described, together with new in vitro approaches of value for
the study of normal and aberrant alveolarization. The need to
examine long-term sequelae of damage to the developing neo-
natal lung is also considered, as is the need to move beyond
the study of the lungs alone in experimental animal models of
BPD.
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Introduction
The lung is the key organ of gas exchange in mammals; it
undertakes the transport of oxygen from inspired air into the
bloodstream and, concomitantly, the transport of carbon diox-
ide out of the circulating blood, which is subsequently exhaled
and thus removed from the body. This gas exchange is facil-
itated by the highly organized structure of the alveolus, the
gas-exchange unit of the lung, where the inspired air is
brought into close proximity to the circulating blood (Hsia
et al. 2016). The close proximity of air and blood is facilitated
by the delicate alveolo-capillary barrier, a double-layered bar-
rier consisting of alveolar epithelial cells that line the alveolar
units containing the inspired air and that are intimately asso-
ciated with the endothelial cells that form the capillaries of the
pulmonary circulation carrying deoxygenated blood through
the lung (Hsia et al. 2016). The blood-air barrier is very thin,
namely 200 nm–2 μm and is permeable to many gases includ-
ing oxygen and carbon dioxide, thus facilitating gas exchange.
Gas exchange occurs by Fick’s Law (Fick 1855) and is a
passive process that is directly determined by (1) the surface
area available over which the gases can diffuse, (2) the dis-
tance across which the gas molecules must diffuse and (3) the
concentration gradient. The broader objective of lung devel-
opment is to generate a gas-exchange structure that satisfies
these three conditions. The structure should have a large sur-
face area and a thin diffusion barrier and should facilitate the
establishment of a steep concentration gradient for gas diffu-
sion in the correct direction. To this end, lung development is
initiated with the emergence of the respiratory diverticulum,
which is a ventral outgrowth of the foregut endoderm, very
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early during embryonic development (the fourth week of ges-
tation in humans). Tracheo-esophageal ridges form from lon-
gitudinal mesodermal folds that Bpinch off^ to separate the
trachea from the esophagus (Herriges and Morrisey 2014;
Morrisey et al. 2013; Morrisey and Hogan 2010; Warburton
et al. 2005). Lung development then proceeds via the forma-
tion of the trachea, which subsequently generates the bronchi-
al tree, forming the conducting airways that develop largely in
parallel with the vasculature that forms the pulmonary circu-
lation (Rawlins 2011). Subsequent lung development over the
canalicular, saccular and alveolar stages generates the alveolar
gas-exchange units (Morty et al. 2009). To satisfy the needs of
Fick’s Law, lung development strives to generate (1) a large
number of small alveoli, thus producing an extremely large
gas-exchange surface area and (2) as thin an alveolo-capillary
barrier as possible to minimize the distance that the diffusing
gases must transit. Furthermore, the proper development of
the conducting airways and conducting blood vessels allows
continuous blood flow in the capillaries and constant air flow
(by breathing) thereby maintaining a steep concentration gra-
dient at the site of the alveolo-capillary barrier. When lung
development proceeds correctly, the lung structure that is gen-
erated is perfectly suited to provide optimal gas exchange
(Herriges and Morrisey 2014; Warburton et al. 2010; West
2013).
Perturbations to lung development result in lungs that are
defective for optimal gas exchange. These perturbations result
in a clinically relevant disease, the most prevalent of which is
bronchopulmonary dysplasia (BPD; Kinsella et al. 2006;
Martin and Fanaroff 2013), a common complication of pre-
term birth originally described by Northway and coworkers in
1967 (Northway et al. 1967). Preterm infants often present
with acute respiratory failure (neonatal or infant respiratory
distress syndrome) that requires oxygen supplementation, in
the most extreme cases, by mechanical ventilation. In affected
infants, a combination of infection, inflammation and oxygen
toxicity, together with physical forces generated by baro- and
volu-trauma from mechanical ventilation, appreciably stunts
the post-natal growth and maturation of the developing lung
(Jain and Bancalari 2014). Over many years, because of
changes in the medical management of pre-term birth, the
histopathological picture of BPD has changed, moving from
lung damage caused by aggressive mechanical ventilation and
oxygen toxicity (Bold BPD^) to a pathology that is distinctly
characterized by disturbances to lung developmental path-
ways (Bnew BPD^; Day and Ryan 2016). This stunting im-
pacts all elements of lung development and the blunted alve-
olar development generates fewer alveoli of a larger size;
hence, the gas-exchange surface area is smaller than it should
be. Additionally, lungs from affected infants are characterized
by thickened alveolar walls, which increase the gas-diffusion
distance between the inspired air in the alveoli and the circu-
lating blood in the capillaries. Furthermore, a dysmorphic
pulmonary vasculature develops, whichmay cause pulmonary
hypertension, thus complicating blood flow through the lung
(Baker and Abman 2015; Hadchouel et al. 2014). BPD is
associated with significant morbidity and mortality in the neo-
natal intensive care unit and survivors exhibit long-term con-
sequences that persist into adulthood (Baraldi and Filippone
2007; Hilgendorff and O’Reilly 2015; Wong et al. 2008).
Disturbances to alveolar structure and to the pulmonary vas-
culature are not exclusive to BPD and can also be seen in
infants with congenital diaphragmatic hernia (CDH; Sluiter
et al. 2012; Veenma et al. 2012). The improvements in the
medical management of preterm birth underlying the transi-
tion from Bold BPD^ to Bnew BPD^ have paradoxically led to
an increase in the incidence of BPD, because preterm infants
born earlier and earlier now survive better (Jobe 2011, 2012;
Jobe and Ikegami 1998; Madurga et al. 2013; Northway
1992); for example, preterm infants born in the 25–28 week
range now have >90 % survival (Stoll et al. 2010). Thus, BPD
represents an increasing clinical burden, underscoring the
need for a better understanding of the aberrant lung develop-
ment in affected neonates. Whereas autopsy material from
BPD non-survivors presents one avenue for the exploration
of pathogenic mechanisms at play in the lungs of affected
patients, this material is increasingly rare and difficult to ob-
tain, because the survival rate of BPD patients has steadily
improved over time. Therefore, most studies addressing path-
ogenic mechanisms that drive BPD pathology are performed
in experimental animals. These experimental animal models
of BPD also serve as an important means of evaluating can-
didate therapeutic interventions, such as novel lead com-
pounds for drug development.
State of the art: pros and cons of animal models
of BPD
Modeling BPD in experimental animals has been the subject
of a large number of recent reviews; therefore, no attempt will
be made here to re-review all of the available models. For this,
the reader is directed to a series of state-of-the-art reviews on
modeling BPD in mice (Berger and Bhandari 2014), rats
(O’Reilly and Thébaud 2014), rabbits (D’Angio and Ryan
2014; Manzano et al. 2014), pre-term lambs (Albertine
2015), pre-term pigs (Arrindell et al. 2015; Caminita et al.
2015) and baboons (Yoder and Coalson 2014). Additionally,
the utility of these models for the study of disease mechanisms
(Hilgendorff et al. 2014) and therapy development (Jobe
2015) has also recently been reviewed.
BPD is most commonly modeled in mice and rats. The
reasons for this are manifold. Mice and rats have relatively
short gestation times (Table 1) and thus, studies that monitor
post-natal lung maturation can be conducted relatively quick-
ly, since lung development in both mice and rats is largely
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complete within the first 2 and 3 weeks of life, respectively.
Additionally, several other practical advantages to working
with mice and rats can be mentioned: both mice and rats are
readily available and easy to maintain compared with larger
vertebrates.Moreover, fewer concerns are raised by regulatory
agencies against experimental studies on rats and mice, than,
for example, experimental studies on non-human primates.
Mice additionally offer a wide availability of many transgenic
lines, although the advent of the CRISPR/Cas9 system should
make the generation of transgenic animals such as rats both
easier and cheaper. The smaller size of mice and rats means
that smaller amounts of pharmacological agents are required
compared with the same dosing of an agent in a larger animal.
Both mice and rats are delivered at term in the saccular
stage of lung development; this fact is often used to justify
the superiority of mice and rats as model animals for BPD,
since preterm infants that develop BPD are also delivered in
the saccular stage of lung development. Thus, termmouse and
rat models appear to be useful models of pre-term birth.
However, we should also keep in mind that, when term mice
and rats are delivered in the saccular stage, these newborn
rodent pups are competent for proper gas exchange and do
not require oxygen supplementation as a life-saving interven-
tion; this is in marked contrast to preterm human neonates
with or at risk for the development of BPD.
The small size of mice and rats at birth is also a disadvan-
tage. Newborn mouse and rat pups are notoriously difficult to
intubate. This is important, since mechanical ventilation is a
highly clinically relevant, injurious stimulus for BPD. Thus,
the maintenance of intubated ventilated newborn mouse and
rat pups over prolonged periods of time is desirable in order to
assess the impact on post-natal lung maturation. Tissue and
cell stretch and lung distention are proposed to be important
causes of tissue damage to the developing lung (Hussein et al.
2013) emphasizing the need for more ventilation-based
models to study the impact of mechanical ventilation on
post-natal lung maturation. For example, an 8-h aggressive
mechanical ventilation period (tidal volume 15 μl/g) of 5-
day-old mouse pups with room air stunts lung alveolarization,
whereas a comparatively gentler mechanical ventilation pro-
tocol (tidal volume 8 μl/g) does not impact alveolarization
(Ratner et al. 2013). Currently, mechanical ventilation can
only be undertaken for short periods of time (up to about
24 h; Berger and Bhandari 2014; Bland et al. 2008) but not
beyond. In this sense, the larger animal models are clearly
superior.
The small size of newborn mouse and rat pups is also a
source of concern with regard to substance administration.
Parenteral administration of pharmacological agents generally
must be via the intraperitoneal route, since intravenous injec-
tion in newborn mouse and rat pups is not possible. The small
size and delicate skin of newborn mouse and rat pups also
makes dosing frequency difficult. For substances with short
half-lives, repeat dosing over short intervals is generally not
possible, since repeated injection at the same injection site
(one is short of options in newborn mouse pups) creates local
trauma and necrosis and the placement of a mini-pump is
impractical. These drawbacks again highlight the utility of
the larger animal models of BPD. Scope for the improvement
of the delivery of agents to newborn mouse pups does how-
ever exist. Whereas many pharmacological agents are short-
lived, some chemical substances have pronounced in vivo sta-
bility. One case in point is that of antagomiRs, which are
synthetic inhibitors of microRNA. MicroRNA are emerging
as exciting modulators of normal and aberrant lung
alveolarization (Nardiello and Morty 2016). The extraordi-
nary stability of antagomiRs makes antagomiRs suitable as
test substances for examining, for example, delivery to new-
born pups via the maternal route, shortly prior to birth. Such
maternal transmission studies might markedly improve agent
delivery to newborn rodent pups, although such studies have
yet to be reported in the literature. Along these lines, other
possible routes of the administration of pharmacological and
other agents include the intra-nasal route, which would be
particularly relevant in the case of respiratory viruses such as
respiratory syncytial virus (RSV) and influenza virus, which
are known to complicate clinical BPD. Additionally, the intra-
uterine administration of substances such as bacterial lipo-
polysaccharide has been employed, to assess an impact of
sterile inflammation on post-natal lung alveolarization (Ueda
et al. 2006). To date, no side-by-side comparison has been
published that has assessed the comparative efficacy of sub-
stance administration by using various routes of substance
administration in utero, via the maternal route, or directly to
newborns.
In spite of the drawbacks highlighted above, rodent models
of BPD are the predominant model in widespread use today.
This predominance has also led to a substantial variance in the
injurious insults applied. A wide variety of mouse strains are
available and many strains are employed on a mixed strain
background. Whereas the C57BL/6 is the most widely-
employed mouse strain, studies have also been reported
Table 1 Stages of mouse and rat lung development compared with that








Embryonic E9-E11.5 E8-E13 3–7
Pseudoglandular E11.5-E16.5 E18-E18 5–17
Canalicular E16.5-E17.5 E18-E20 16–29
Saccular E17.5-P5 E20-P5 24–38
Alveolar P5-P28 P5-P30 32-adolescence
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involving BALB/c, FVB/n and C3H background strains and
mixed backgrounds containing some 129S strain components
(Silva et al. 2015). This concerns hyperoxia studies, since
tremendous variation is present in the susceptibility of adult
mice of different strains to hyperoxia (Hudak et al. 1993;
Whitehead et al. 2006). This use of diverse mouse strains
sometimes makes the comparisons of independent studies
problematic. A systematic comparison of the susceptibility
of the various mouse strains to hyperoxia, particularly
concerning the impact of hyperoxia and mechanical ventila-
tion on post-natal lung maturation, is a study that urgently
needs to be conducted in order to allow investigators to make
informed decisions about which mouse strain might be useful
in studies in experimental mouse models of BPD. The impor-
tance of this idea is underscored by the tremendous influence
of the mouse strain on fibrogenic responses to transforming
growth factor-β (Kolb et al. 2002), which is a knownmediator
of aberrant lung development in the hyperoxia-based mouse
model of BPD (Alejandre-Alcázar et al. 2007; Nakanishi et al.
2007).
Another area in which tremendous variation in animal
models is evident is in the degree of oxygen injury employed.
Term mouse and term rat models can be used, with a range of
oxygen injury protocols being currently implemented. These
are summarized (evaluating literature from the past 3 years) in
Table 2. Although the use of diverse oxygen injury protocols
is fruitful, a standardized protocol would also be helpful so
that studies undertaken by diverse groups can be directly com-
pared side-by-side. To this end, a systematic comparison of
the impact of various oxygen concentrations would be of great
value for the community. In this respect, a study of the impact
of gradual versus abrupt changes in inspired oxygen concen-
trations on lung alveolarization needs to be conducted in order
to consider the translational implications of gradual weaning.
Along these lines, from an animal welfare point of view, the
determination of the Bwindows^ of post-natal lung develop-
ment that are sensitive to oxygen injury would be advanta-
geous. Currently, many investigators simply expose newborn
rodents to elevated oxygen concentrations for fixed periods of
time, for example, from the day of birth to post-natal day
(P)14, at which time point the bulk alveolarization that takes
place over the immediate postnatal period is largely complete.
However, much shorter durations of hyperoxia exposure (such
as a window spanning the Bpeak^ period of secondary
septation in mice; say P3-P7) would be sufficient to recapitu-
late the lung histopathological characteristics of BPD. Such a
systematic study examining the effects of a defined oxygen
concentration over discrete windows of postnatal lung devel-
opment in rodents has yet to be performed. Thus, whereas the
use of mouse and rat models is widespread, these models are
not without substantial drawbacks leading some investigators
to explore other experimental animal models of preterm birth
and BPD.
Rabbits represent the middle-ground between small verte-
brates such as rats and mice and larger vertebrates such as
sheep, pigs and nonhuman primates (Table 3). Unlike mice
and rats, rabbit kits can be delivered preterm by caesarian
section and can then be subjected to mechanical ventilation
(as instrumentation is substantially easier in rabbit kits than in
newborn mouse and rat pups). A preterm rabbit model with
hyperoxia exposure has been described (Manzano et al. 2014;
Richter et al. 2014; Salaets et al. 2015) and the use of preterm
rabbits continues to be refined (D’Angio and Ryan 2014;
Manzano et al. 2014).
Prior to the development of the rabbit model, preterm
lambs proved most useful for the modeling of BPD and con-
tinue to be used today (Albertine 2015; Brew et al. 2013;
Collins et al. 2013a; Galinsky et al. 2013; Hillman et al.
2013; Kallapur et al. 2013; Null et al. 2014). The ability to
deliver lambs preterm is particularly appealing for
translationally relevant modeling of BPD and the larger size
of preterm lambs, compared with preterm rabbits, makes in-
strumentation and mechanical ventilation easier. Clearly, sub-
stantial costs are associated with the preterm lamb model.
Apart from lambs, renewed interest has been shown in the
use of term and preterm piglets to study BPD (Bartlett et al.
2013; Caminita et al. 2015); preterm piglets exhibit ventilation
inadequacies, together with clinically comparable risks for the
development of respiratory disease syndrome. Thus, piglets
represent an alternative to nonhuman primates and lambs.
Primates have been considered the most translationally rel-
evant models for BPD; however, the extraordinary costs of
primate studies, together with complex ethical considerations,
have led to a decline in the use of primates tomodel BPD. Two
widely used preterm primate models are available (Yoder and
Coalson 2014): (1) the 140-day premature baboon model in
which preterm baboons are ventilated with high pressures and
an FiO2 of up to 100 % oxygen for several days is believed
histopathologically to mimic Bold BPD^ (Escobedo et al.
1982); (2) the 125-day premature baboon model in which
preterm baboons are ventilated with low tidal volume or nasal
continuous positive airway pressure and an FiO2 tailored to
individual need (up to and beyond 28 days) is believed to
mimic more closely Bnew BPD^ (Coalson et al. 1999;
Maniscalco et al. 2002). The latter model is occasionally com-
bined with intrauterine exposure to Ureaplasma, which fre-
quently results in preterm labor (Yoder and Coalson 2014).
The relative phylogenetic closeness of non-human primates to
humans, compared with rodents and the ability to deliver non-
human primates pre-term have clear advantages for transla-
tional research into new BPD. Primates are also often suscep-
tible to the same or related viruses that complicate clinical
BPD. For example, newborn baboons can be infected with
RSV and also develop pathological features consistent with
RSV infection in human neonates (Papin et al. 2013). This is
important, since RSV remains an important clinical problem
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in a neonatal intensive care setting (Carpenter and Stenmark
2004). In addition to clinical and anatomic parallels, non-
human primates may be more useful for the study of the
long-term sequelae of BPD associated with pre-term birth,
i n c l u d i n g e x t r a - p u lmon a r y s e q u e l a e s u c h a s
neurodevelopmental outcomes, since cognition studies on






40 P1-P7 Recovery in 21% O2 P7-P21 Wang et al. 2014
50/10 P1-P14 Oscillation; recovery in 21% O2 P14-P21 M. Chang et al. 2013
60 P1-P14 Ahlfeld et al. 2013; Belcastro et al. 2015; Masood et al. 2014
70 P3-P13 Bachiller et al. 2013
75 P1-P7 Harijith et al. 2013
75 P1-P14 Monz et al. 2013
75 P1-P14 Prenatal hypoxia (10% O2) Gortner et al. 2013
75 P2-P17 Popova et al. 2014
75 P3-P27 Anyanwu et al. 2014
80 P6-P8 Weichelt et al. 2013
80 P1-P7 Prenatal LPS, recovery in 21% O2 P7-P14 Lee et al. 2014
80 P1-P15 Dayanim et al. 2014
80 P1-P7 Recovery in 21% O2 P8-P21 Pham et al. 2014
80 P1-P28 Recovery in 21% O2 P28-P56 Tibboel et al. 2015
85 P1-P7 James et al. 2013; Koskinen et al. 2014; Witsch et al. 2014a, 2014b
85 P2-P9 Park et al. 2013
85 P1-P10 Madurga et al. 2014
85 P1-P14 Ahlfeld et al. 2013; Britt et al. 2013; James et al. 2013; Raffay et al. 2013
85 P4-P14 Alphonse et al. 2014
85 P2-P8 Recovery in 21% O2 P8-P16 Park et al. 2013
85 P1-P14 Recovery in 21% O2 P14-P28 James et al. 2013; Raffay et al. 2013; Rieger-Fackeldey et al. 2014
85/gradient P1-P28 85% O2 P1-P14, followed by gradient from
85% O2 to 21% O2 between P14 and P28
Rieger-Fackeldey et al. 2014
90 P3-P10 Recovery in 21% O2 P10-P14 Ramachandran et al. 2015
90 P1-P14 Ahn et al. 2015
90 P2-P15 Hummler et al. 2013
90 P1-P14 Recovery in 21% O2 P14-P15 Alapati et al. 2014
90 P1-P15 Sutsko et al. 2013
90 P2-P15 Recovery in 21% O2 P15-P28 Miranda et al. 2013
90 P1-P15 Recovery in 21% O2 P15-P29 Sutsko et al. 2013
95 P1-P7 Initiated pre-natally Richter et al. 2014
90/60 P1-P21 90% O2 P1-P14, 60% O2 P14-P21 Y.S. Chang et al. 2013
95 P4-P14 Alphonse et al. 2014
95 P1-P14 Alphonse et al. 2014; McKenna et al. 2014; Vadivel et al. 2014
95 P1-P6 Recovery in 21% O2 P6-P21 Sakurai et al. 2013
95 P1-P7 Recovery in 21% O2 P7-P56 Ahlfeld et al. 2015
100 P1-P3.5 Kawamura et al. 2013
100 P1-P7 Sureshbabu et al. 2015
100 P1-P7 With LPS application Syed and Bhandari 2013
100 P1-P10 Bhattacharya et al. 2014; Martin et al. 2014; Wagenaar et al. 2013a, 2013b
100 P1-P4 Recovery in 21% O2 P4-P56 Buczynski et al. 2013
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baboons are well established (Zürcher et al. 2010). From a
translational medicine point of view (for example, the assess-
ment of novel therapeutic approaches or the assessment of
long-term neurodevelopmental outcomes), the baboonmodels
are unquestionably an ideal model, despite grave ethical con-
cerns and considerable cost. In contrast, for the study of path-
ogenic pathways, whereby artificial modulation of gene ex-
pression is required implicate causality, rodent models remain
the method of choice in terms of cost, convenience and tool
availability.
In summary, a spectrum of experimental animals has
proved useful as model organisms to study BPD, with partic-
ular advantages and disadvantages associated with the use of
the various model organisms. Given issues of cost, ethics, time
and the availability of transgenic animals, the mouse will
probably remain the most widely used model for BPD.
Whereas hyperoxia and mechanical ventilation have been
highlighted as the predominant injurious stimuli for BPD
models, much scope remains for an improvement of the way
that we induce arrested lung development in BPD models. In
this respect, much interest has been shown in sterile and
infection-driven inflammation, such as intrauterine inflamma-
tion, either singly or in combination with mechanical ventila-
tion or hyperoxia exposure, as a Bsecond hit^ (Collins et al.
2013a, 2013b; Yoo et al. 2013). These inflammation-based
models are important and clinically relevant BPD models that
demand more development and increased use.
Assessment of lung structure: stereological
and three-dimensional approaches
Most BPD models today are employed in studies involving
perturbations to the development of lung structure. Of note at
this junction, the clinical definition of BPD does not in any
way include structural elements of lung development. In a
neonatal intensive care setting, the diagnosis of BPD is cur-
rently based on the need for supplemental oxygen for at least
28 days after birth and its severity is graded according to the
respiratory support required at 36 postmenstrual weeks
(Jobe 2011, 2012). This does not directly take into account
lung structure or perturbations to lung development.
Nevertheless, most experimental investigations address the
mechanisms underlying stunted lung development and exploit
animal models to explore candidate interventions with the aim
of promoting lung growth and alveolarization. Thus, the abil-
ity effectively to quantify changes in lung structure, most im-
portantly with regard to the size and abundance of the alveoli,
the gas-exchange surface area, the vascularization of the lung
and the thickness of the septal walls, is clearly important.
The quantification of lung structure is currently undergoing
a revolution. Historically, structural analysis of the lung has
been undertaken in paraffin-embedded lung tissue and lung
structure was analyzed through the determination of the mean
linear intercept (MLI) and radial alveolar count (RAC) as
surrogates of the size of the alveoli (Silva et al. 2015). These
determinations are generally made by direct measurements of
the distance between adjacent walls of an alveolus by means
of a slide rule. The thickness of the alveolar wall can be sim-
ilarly measured by visual inspection; however, both ap-
proaches are not unbiased. Of greater concern is the distortion
of the lung structure that occurs during the tissue processing,
namely, the dehydration and rehydration of the lung for par-
affin embedding (Schneider and Ochs 2014). These are im-
portant concerns, although we must also acknowledge that
these more classical approaches form the basis of most of
the important observations made to date regarding not only
pathological mechanisms of BPD but also drug discovery
(Liao et al. 2015; Olave et al. 2015; Schneider and Ochs
2014; Tibboel et al. 2013). To address concerns about bias
in analyses and the generation of artifacts during tissue pro-
cessing, much effort has been expended on replacing paraffin
embedding with embedding in plastic resins, together with the
treatment of lung tissue with osmium and uranium in order to
preserve lung structure (Schneider and Ochs 2014).
Additionally, design-based stereology methodologies are un-
biased, have higher precision (Schneider and Ochs 2013;
Tschanz et al. 2014a), and thus represent an advance over
the classical MLI and RAC methods (Mühlfeld and Ochs
2013; Ochs and Mühlfeld 2013). Design-based stereology
Table 3 Stages of lung
development in larger animals
compared with that of humans
Stage Gestational age
(days)
Rabbit Sheep Pig Baboon Human
Term 32 147 115 168–185 280
Embryonic Up to 18 Up to 40 Up to 25 Up to 42 Up to 42
Pseudoglandular 21–24 40–80 22–56 Up to 80 52–112
Canalicular 24–27 80–110 56–98 80–120 112–168
Saccular From 27 110–130 From 99 120–140 From 168
Alveolar From 30 From 130 From 104 From 140 From 252
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has recently been applied to the analysis of lung structure in
newborn mice (Madurga et al. 2014, 2015; Mižíková et al.
2015) and rats (Tschanz et al. 2014b) and these technologies
continue to evolve. Whereas the estimation of alveoli number,
gas-exchange surface area and the thickness of the septal wall
has developed well, the quantification of vascular structure
remains under-developed. Historically, surrogate measures
for capillary Bdensity^ have been the quantification of
immune-histochemical staining of endothelial cell markers
in low-power microscopic fields. However, this approach is
fraught with pitfalls. Recent work addressing the quantifica-
tion of capillaries in the lung by using a stereological approach
is an important step in the right direction (Knust et al. 2009;
Mühlfeld 2014; Willführ et al. 2015) and will no doubt con-
tinue to be refined.
If we remain with the topic of microscopy, although not in a
quantitative sense, recent exciting studies concerning the
three-dimensional reconstruction of serial sections of lungs
from patients with BPD have revealed the presence of
intrapulmonary anastomoses that would not have been detect-
ed in two-dimensional microscopy studies (Galambos et al.
2013). This highlights the tremendous utility of the three-
dimensional visualization of lung structures in aberrantly de-
veloping lungs. One exciting recent report addresses the three-
dimensional study of alveologenesis in mice undergoing nor-
mal lung development (Branchfield et al. 2016). These types
of approaches have not been employed in lung tissue taken
from animal models of BPD but this remains on the Bto do
list^. Furthermore, the availability of transgenic driver mice
with facilitated fluorescent labeling of discrete cell types in the
lung should allow for studies of cell-cell interactions during
lung development. Such an experimental set-upmight be used
to explore endothelial-epithelial contact and whether these
contacts are preserved under conditions of stunted lung
growth and blunted alveolarization.
In vitro studies
The development of the three-dimensional architecture of the
alveolus demands that alveolarization is studied in intact living
animals. However, elements of alveolarization can also be stud-
ied in ex vivo tissue from animal models of BPD. An increas-
ing number of reports are appearing in the literature detailing
such ex vivo studies. These approaches include the use of co-
cultures (Greer et al. 2014; Lewis et al. 2015; Pieretti et al.
2014) to address cell-cell interactions and cell phenotypic trans-
formation during alveolarization, plus in-vitro-generated lung
organoids that appear to undergo processes akin to
alveolarization (Dye et al. 2015; Quantius et al. 2016).
Evidence has also been presented that lung sections harvested
from developing mouse lungs and maintained in culture con-
tinue to undergo secondary septation (Pieretti et al. 2014). This
provides a potentially exciting means of intervening in devel-
opmental and pathogenic pathways; such intervention cannot
be performed in living animals for reasons of toxicity. These
cultured lung explants can be manipulated, for example,
through artificial stretch (Davidovich et al. 2013), which might
be used to mimic the impact of mechanical ventilation in vitro.
The wide availability of cell-type-specific mouse driver lines
has introduced the possibility of directly assessing communi-
cation between specific cell types during alveolarization, for
example, in the in vitro alveolarization studies mentioned
above and also by using the previously described organoid
systems in which cells derived from particular driver lines
can be recombined in vitro. This might be particularly relevant,
for example, to the study of the various fibroblast lineages, such
as platelet-derived growth factor receptor (PDGF)-α-labeled
fibroblasts, including the PDGFRαhi and PDGFRαlow subpop-
ulations of lung fibroblasts that have been accredited with dif-
ferent signaling roles in vivo during lung alveologenesis
(McGowan and McCoy 2015; Ntokou et al. 2015; Ruiz-
Camp and Morty 2015).
Perspective: where do we go from here?
The modeling of BPD in animals can be improved and devel-
oped in many areas. Use of oxygen as an injurious stimulus is
likely to remain a key driver of pathology in experimental
animal models of BPD, irrespective of whether low levels
(40 % O2) or high levels (85 % O2) of oxygen are employed.
Much scope remains for the improvement of the pure
hyperoxia-based models. A very large range of oxygen con-
centrations have been employed, from 40 % O2 to 100 % O2,
in a variety of exposure protocols, with and without a Bsecond
hit^, which has both advantages and disadvantages. Amongst
the advantages is that much has been learnt about how (much)
oxygen injures the developing lung. However, the use of a
broad range of oxygen exposure protocols has also yielded
data (and conclusions) from various investigators in the field
but these data are difficult to compare side-by-side. A system-
atic comparison of hyperoxia exposure protocols would be a
most useful addition to the body of literature on animal
models of BPD, as would a comparison of the effects of
hyperoxia on different mouse strain backgrounds. The further
development of translationally relevant Btwo-hit^ models re-
mains a priority area in experimental animal studies on BPD,
as does the technological development of mechanical ventila-
tion and instrumentation of very small newborn rodents.
As highlighted above, the clinical definition of BPD relates
to a need for – and the degree of – oxygen supplementation at
defined time-points during postnatal life. Lung structure is not
considered within that definition. The lack of physiological
studies on respiratory function in animal models of BPD is
remarkable and warrants attention. Some investigators have
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taken steps to address the relationship of lung structure to
the functional impairment of respiratory function (Ahlfeld
et al. 2015) and more studies along these lines are urgent-
ly needed. The delineation of the degree of the stunting to
alveolarization that results in an appreciable impact on
gas-exchange physiology in experimental animal models
of BPD would be welcome.
The rapid pace of technological development of in vivo
imaging, microscopy and computational analysis highlights
the utility of these approaches to the study of aberrant lung
development in experimental animal models. Notable
amongst these is the three-dimensional reconstruction of pa-
thology samples, as this method might reveal anatomical dis-
turbances not evident from two-dimensional analyses. The
ability to manipulate lung sections ex vivo in cell culture
brings with it new possibilities for the analysis and interven-
tion in lung development pathways; such investigations might
not be possible in intact living animals.
As a final point, we also need to broaden our horizons, both
beyond the immediate post-natal period and beyond the lung.
BPD is known to have sequelae that persist into adulthood and
yet, our understanding of the long-term consequences of ex-
posure to hyperoxia, pulmonary infection and inflammation
and mechanical ventilation in neonates remains relatively
understudied. This is a matter of intensive investigation by
some groups, such as that of Michael O’Reilly at the
University of Rochester and further exploration of the way
that an insult to the developing lung in the postnatal period
impacts lung (and general) health in later life is an important
area for future work involving the use of experimental animal
models of BPD. If we move beyond the lung, neonates
with BPD are known to be at risk of serious extra-
pulmonary morbidities, including (but not limited to) ad-
verse neurodevelopmental outcomes and retinopathy of
prematurity. Important work to address extra-pulmonary
morbidity in a hyperoxia-based model of BPD in rodents
has now started to emerge (Bravo-Nuevo et al. 2016;
Poon et al. 2016). These issues have hardly been studied
at all in experimental animal models of BPD and would
most likely yield some exciting experimental data.
Summary: neglected areas and urgent needs
The application of animal models for the study of BPD con-
tinues to be refined and improved. Several neglected areas
currently warrant attention by investigators. (1) Whereas the
diversity of animal models of BPD represents a strength of the
field, the lack of standardization of the rodent models, in par-
ticular, the hyperoxia-based rodent models, can be problemat-
ic. Ideally, optimization studies would identify as low an FiO2
as possible (which would be in agreement with clinical prac-
tice and would embrace concerns about animal welfare) that
still recapitulates the pathological hallmarks of BPD. Studies
that systematically compare, side-by-side, the impact of di-
verse oxygen exposure protocols on lung alveolarization are
needed. In this respect, the long-term consequences of
perturbed lung development in the immediate post-natal peri-
od will be an important aspect to address in animal models. (2)
The analysis of lung structure has rapidly developed over the
past few years, with increased implementation of design-
based stereological approaches for the analysis of selected
elements of lung structure, for example, the alveoli.
However, the stereological analysis of lung vascular develop-
ment, in particular, the capillaries, remains under-developed.
Given that perturbed vascular development is a complication
of both clinical and experimental BPD, further refinement of
the analysis of lung vascular structures is a priority area. With
regard to imaging, the development of alternative approaches
to the quantification of lung structure would be desirable.
Amongst these are refinement in the visualization and analysis
of lung structure in three dimensions and radiological ap-
proaches to facilitate serial measurement of the development
of the lung in the same animal over an experimental time-
course. (3) Although many studies addressing the pathogene-
sis and management of BPD in animal models utilize a struc-
tural analysis of the lung as a primary readout, few studies
support these structural analyses with physiological readouts
of gas exchange and lung function. Lung function analyses are
routinely performed in studies on adult experimental animals,
for example, by utilizing the FlexiVent system or whole-body
plethysmography; however, these approaches have not been
adapted to newborn or juvenile (developing) animals,
largely because of technical limitations. The inclusion
of lung function data is highly desirable in future studies
utilizing animal models of BPD. (4) Given that clinical
BPD has a massive impact on several extra-pulmonary issues,
including retinopathy and neurodevelopmental outcomes, we
urgently need to consider extra-pulmonary effects in animal
models of BPD. Thus, much exciting work remains to be
done!
Acknowledgements Open Access funding provided by Max Planck
Society. This study was financially supported by the Max Planck
Society, by Rhön Klinikum grant Fl_66, by the Federal Ministry of
Higher Education, Research and the Arts of the State of Hessen
BLOEWE Programme^, by the German Center for Lung Research
(Deutsches Zentrum für Lungenforschung), by the German Research
Foundation (Deutsche Forschungsgemeinschaft) through Excellence
Cluster EXC147, Collaborative Research Center SFB1213/1, Clinical
Research Unit KFO309/1 and by individual research grant Mo 1789/1.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted
use, distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made.
464 Cell Tissue Res (2017) 367:457–468
References
Ahlfeld SK, Gao Y, Wang J, Horgusluoglu E, Bolanis E, Clapp DW,
Conway SJ (2013) Periostin downregulation is an early marker of
inhibited neonatal murine lung alveolar septation. Birth Defects Res
A Clin Mol Teratol 97:373–385
Ahlfeld SK, Gao Y, Conway SJ, Tepper RS (2015) Relationship of struc-
tural to functional impairment during alveolar-capillary membrane
development. Am J Pathol 185:913–919
Ahn SY, Chang YS, Sung DK, Yoo HS, Sung SI, Choi SJ, Park WS
(2015) Cell type-dependent variation in paracrine potency deter-
mines therapeutic efficacy against neonatal hyperoxic lung injury.
Cytotherapy 17:1025–1035
Alapati D, Rong M, Chen S, Hehre D, Hummler SC, Wu S (2014)
Inhibition of beta-catenin signaling improves alveolarization and
r edu c e s pu lmona r y hype r t e n s i o n i n expe r imen t a l
bronchopulmonary dysplasia. Am J Respir Cell Mol Biol 51:104–
113
Albertine KH (2015) Utility of large-animal models of BPD: chronically
ventilated preterm lambs. Am J Physiol Lung Cell Mol Physiol 308:
L983–L1001
Alejandre-Alcázar MA, Kwapiszewska G, Reiss I, Amarie OV, Marsh
LM, Sevilla-Pérez J, Wygrecka M, Eul B, Köbrich S, Hesse M,
Schermuly RT, Seeger W, Eickelberg O, Morty RE (2007)
Hyperoxia modulates TGF-beta/BMP signaling in a mouse model
of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol
Physiol 292:L537–L549
Alphonse RS, Vadivel A, Fung M, Shelley WC, Critser PJ, Ionescu L,
O’Reilly M, Ohls RK, McConaghy S, Eaton F, Zhong S, Yoder M,
Thebaud B (2014) Existence, functional impairment, and lung repair
potential of endothelial colony-forming cells in oxygen-induced
arrested alveolar growth. Circulation 129:2144–2157
Anyanwu AC, Bentley JK, Popova AP, Malas O, Alghanem H,
Goldsmith AM, Hershenson MB, Pinsky DJ (2014) Suppression
of inflammatory cell trafficking and alveolar simplification by the
heme oxygenase-1 product carbon monoxide. Am J Physiol Lung
Cell Mol Physiol 306:L749–L763
Arrindell EL Jr, Krishnan R, van der Merwe M, Caminita F, Howard SC,
Zhang J, Buddington RK (2015) Lung volume recruitment in a
preterm pig model of lung immaturity. Am J Physiol Lung Cell
Mol Physiol 309:L1088–L1092
Bachiller PR, Cornog KH, Kato R, Buys ES, Roberts JD Jr (2013)
Soluble guanylate cyclase modulates alveolarization in the newborn
lung. Am J Physiol Lung Cell Mol Physiol 305:L569–L581
Baker CD, Abman SH (2015) Impaired pulmonary vascular development
in bronchopulmonary dysplasia. Neonatology 107:344–351
Baraldi E, FilipponeM (2007) Chronic lung disease after premature birth.
N Engl J Med 357:1946–1955
Bartlett JA, Albertolle ME, Wohlford-Lenane C, Pezzulo AA, Zabner J,
Niles RK, Fisher SJ, McCray PB Jr, Williams KE (2013) Protein
composition of bronchoalveolar lavage fluid and airway surface
liquid from newborn pigs. Am J Physiol Lung Cell Mol Physiol
305:L256–L266
Belcastro R, Lopez L, Li J, Masood A, Tanswell AK (2015) Chronic lung
injury in the neonatal rat: up-regulation of TGFbeta1 and nitration of
IGF-R1 by peroxynitrite as likely contributors to impaired
alveologenesis. Free Radic Biol Med 80:1–11
Berger J, Bhandari V (2014) Animal models of bronchopulmonary dys-
plasia. The term mouse models. Am J Physiol Lung Cell Mol
Physiol 307:L936–L947
Bhattacharya S, Zhou Z, Yee M, Chu CY, Lopez AM, Lunger VA, Solleti
SK, Resseguie E, Buczynski B, Mariani TJ, O’Reilly MA (2014)
The genome-wide transcriptional response to neonatal hyperoxia
identifies Ahr as a key regulator. Am J Physiol Lung Cell Mol
Physiol 307:L516–L523
Bland RD, Ertsey R, Mokres LM, Xu L, Jacobson BE, Jiang S, Alvira
CM, Rabinovitch M, Shinwell ES, Dixit A (2008) Mechanical ven-
tilation uncouples synthesis and assembly of elastin and increases
apoptosis in lungs of newborn mice. Prelude to defective alveolar
septation during lung development? Am J Physiol Lung Cell Mol
Physiol 294:L3–L14
Branchfield K, Li R, Lungova V, Verheyden JM, McCulley D, Sun X
(2016) A three-dimensional study of alveologenesis in mouse lung.
Dev Biol 409:429–441
Bravo-Nuevo A, Brandli AA, Gerhart J, Nichols J, Pitts M, Sutera CK,
Assali S, Scheinfeld V, Prendergast GC, Stone J, George-Weinstein
M (2016) Neuroprotective effect of Myo/Nog cells in the stressed
retina. Exp Eye Res 146:22–25
Brew N, Hooper SB, Zahra V, Wallace M, Harding R (2013) Mechanical
ventilation injury and repair in extremely and very preterm lungs.
PLoS One 8:e63905
Britt RD Jr, Velten M, Tipple TE, Nelin LD, Rogers LK (2013)
Cyclooxygenase-2 in newborn hyperoxic lung injury. Free Radic
Biol Med 61:502–511
Buczynski BW, Yee M, Martin KC, Lawrence BP, O’Reilly MA (2013)
Neonatal hyperoxia alters the host response to influenza A virus
infection in adult mice through multiple pathways. Am J Physiol
Lung Cell Mol Physiol 305:L282–L290
Caminita F, van der Merwe M, Hance B, Krishnan R, Miller S,
Buddington K, Buddington RK (2015) A preterm pig model of lung
immaturity and spontaneous infant respiratory distress syndrome.
Am J Physiol Lung Cell Mol Physiol 308:L118–L129
Carpenter TC, Stenmark KR (2004) Predisposition of infants with chron-
ic lung disease to respiratory syncytial virus-induced respiratory
failure: a vascular hypothesis. Pediatr Infect Dis J 23:S33–S40
Chang M, Bany-Mohammed F, Kenney MC, Beharry KD (2013) Effects
of a superoxide dismutase mimetic on biomarkers of lung angiogen-
esis and alveolarization during hyperoxia with intermittent hypoxia.
Am J Transl Res 5:594–607
Chang YS, Choi SJ, Ahn SY, Sung DK, Sung SI, Yoo HS, Oh WI, Park
WS (2013) Timing of umbilical cord blood derived mesenchymal
stem cells transplantation determines therapeutic efficacy in the neo-
natal hyperoxic lung injury. PLoS One 8:e52419
Coalson JJ, Winter VT, Siler-Khodr T, Yoder BA (1999) Neonatal chron-
ic lung disease in extremely immature baboons. Am J Respir Crit
Care Med 160:1333–1346
Collins JJ, Kallapur SG, Knox CL, KempMW, Kuypers E, Zimmermann
LJ, Newnham JP, JobeAH, Kramer BW (2013a) Repeated intrauter-
ine exposures to inflammatory stimuli attenuated transforming
growth factor-beta signaling in the ovine fetal lung. Neonatology
104:49–55
Collins JJ, Kunzmann S, Kuypers E, KempMW, Speer CP, Newnham JP,
Kallapur SG, Jobe AH, Kramer BW (2013b) Antenatal glucocorti-
coids counteract LPS changes in TGF-beta pathway and caveolin-1
in ovine fetal lung. Am J Physiol Lung Cell Mol Physiol 304:L438–
L444
D’Angio CT, Ryan RM (2014) Animal models of bronchopulmonary
dysplasia. The preterm and term rabbit models. Am J Physiol
Lung Cell Mol Physiol 307:L959–L969
Davidovich N, Huang J, Margulies SS (2013) Reproducible uniform
equibiaxial stretch of precision-cut lung slices. Am J Physiol Lung
Cell Mol Physiol 304:L210–L220
Day CL, Ryan RM (2016) Bronchopulmonary dysplasia: new becomes
old again! Pediatr Res (in press)
Dayanim S, Lopez B, Maisonet TM, Grewal S, Londhe VA (2014)
Caffeine induces alveolar apoptosis in the hyperoxia-exposed devel-
oping mouse lung. Pediatr Res 75:395–402
Dye BR, Hill DR, Ferguson MA, Tsai YH, Nagy MS, Dyal R, Wells JM,
Mayhew CN, Nattiv R, Klein OD, White ES, Deutsch GH, Spence
JR (2015) In vitro generation of human pluripotent stem cell derived
lung organoids. eLife 4:e05098
Cell Tissue Res (2017) 367:457–468 465
Escobedo MB, Hilliard JL, Smith F, Meredith K, Walsh W, Johnson D,
Coalson JJ, Kuehl TJ, Null DM Jr, Robotham JL (1982) A baboon
model of bronchopulmonary dysplasia. I. Clinical features. ExpMol
Pathol 37:323–334
Fick A (1855) Über Diffusion. Pogg Ann Physik Chemie 94:59–86
Galambos C, Sims-Lucas S, Abman SH (2013) Histologic evidence of
intrapulmonary anastomoses by three-dimensional reconstruction in
severe bronchopulmonary dysplasia. Ann Am Thorac Soc 10:474–
481
Galinsky R, Polglase GR, Hooper SB, Black MJ, Moss TJ (2013) The
consequences of chorioamnionitis: preterm birth and effects on de-
velopment. J Pregnancy 2013:412831
Gortner L, Monz D, Mildau C, Shen J, Kasoha M, Laschke MW, Roolfs
T, Schmiedl A, Meier C, Tutdibi E (2013) Bronchopulmonary dys-
plasia in a double-hit mouse model induced by intrauterine hypoxia
and postnatal hyperoxia: closer to clinical features? Ann Anat 195:
351–358
Greer RM, Miller JD, Okoh VO, Halloran BA, Prince LS (2014)
Epithelial-mesenchymal co-culture model for studying alveolar
morphogenesis. Organogenesis 10:340–349
Hadchouel A, Franco-Montoya ML, Delacourt C (2014) Altered lung
development in bronchopulmonary dysplasia. Birth Defects Res A
Clin Mol Teratol 100:158–167
Harijith A, Pendyala S, Reddy NM, Bai T, Usatyuk PV, Berdyshev E,
Gorshkova I, Huang LS, Mohan V, Garzon S, Kanteti P, Reddy SP,
Raj JU, Natarajan V (2013) Sphingosine kinase 1 deficiency confers
protection against hyperoxia-induced bronchopulmonary dysplasia
in a murine model: role of S1P signaling and Nox proteins. Am J
Pathol 183:1169–1182
Herriges M, Morrisey EE (2014) Lung development: orchestrating the
generation and regeneration of a complex organ. Development 141:
502–513
Hilgendorff A, O’Reilly MA (2015) Bronchopulmonary dysplasia early
changes leading to long-term consequences. Front Med (Lausanne)
2:2
Hilgendorff A, Reiss I, Ehrhardt H, Eickelberg O, Alvira CM (2014)
Chronic lung disease in the preterm infant. Lessons learned from
animal models. Am J Respir Cell Mol Biol 50:233–245
Hillman NH, Kemp MW, Noble PB, Kallapur SG, Jobe AH (2013)
Sustained inflation at birth did not protect preterm fetal sheep from
lung injury. Am J Physiol Lung Cell Mol Physiol 305:L446–L453
Hsia CC, Hyde DM, Weibel ER (2016) Lung structure and the intrinsic
challenges of gas exchange. Comp Physiol 6:827–895
Hudak BB, Zhang LY, Kleeberger SR (1993) Inter-strain variation in
susceptibil i ty to hyperoxic injury of murine airways.
Pharmacogenetics 3:135–143
Hummler SC, Rong M, Chen S, Hehre D, Alapati D, Wu S (2013)
Targeting glycogen synthase kinase-3beta to prevent hyperoxia-
induced lung injury in neonatal rats. Am J Respir Cell Mol Biol
48:578–588
Hussein O, Walters B, Stroetz R, Valencia P, McCall D, Hubmayr RD
(2013) Biophysical determinants of alveolar epithelial plasma mem-
brane wounding associated with mechanical ventilation. Am J
Physiol Lung Cell Mol Physiol 305:L478–L484
Jain D, Bancalari E (2014) Bronchopulmonary dysplasia: clinical per-
spective. Birth Defects Res A Clin Mol Teratol 100:134–144
James ML, Ross AC, Nicola T, Steele C, Ambalavanan N (2013) VARA
attenuates hyperoxia-induced impaired alveolar development and
lung function in newborn mice. Am J Physiol Lung Cell Mol
Physiol 304:L803–L812
Jobe AH (2011) The new bronchopulmonary dysplasia. Curr Opin
Pediatr 23:167–172
Jobe AH (2012)What is BPD in 2012 and what will BPD become? Early
Hum Dev 88 (Suppl 2):S27–S28
Jobe AH (2015) Animal models, learning lessons to prevent and treat
neonatal chronic lung disease. Front Med (Lausanne) 2:49
Jobe AH, Ikegami M (1998) Mechanisms initiating lung injury in the
preterm. Early Hum Dev 53:81–94
Kallapur SG, Kramer BW, Jobe AH (2013) Ureaplasma and BPD. Semin
Perinatol 37:94–101
Kawamura T, Wakabayashi N, Shigemura N, Huang CS, Masutani K,
Tanaka Y, Noda K, Peng X, Takahashi T, Billiar TR, Okumura M,
Toyoda Y, Kensler TW, Nakao A (2013) Hydrogen gas reduces
hyperoxic lung injury via the Nrf2 pathway in vivo. Am J Physiol
Lung Cell Mol Physiol 304:L646–L656
Kinsella JP, Greenough A, Abman SH (2006) Bronchopulmonary dys-
plasia. Lancet 367:1421–1431
Knust J, Ochs M, Gundersen HJ, Nyengaard JR (2009) Stereological
estimates of alveolar number and size and capillary length and sur-
face area in mice lungs. Anat Rec (Hoboken) 292:113–122
Kolb M, Bonniaud P, Galt T, Sime PJ, Kelly MM,Margetts PJ, Gauldie J
(2002) Differences in the fibrogenic response after transfer of active
transforming growth factor-beta1 gene to lungs of Bfibrosis-prone^
and Bfibrosis-resistant^ mouse strains. Am J Respir Cell Mol Biol
27:141–150
Koskinen A, Lukkarinen H, Laine J, Ahotupa M, Kaapa P, Soukka H
(2014) Delay in rat lung alveolarization after the combined exposure
of maternal hyperglycemia and postnatal hyperoxia. Pediatr
Pulmonol 49:179–188
Lee HJ, Lee YJ, Choi CW, Lee JA, Kim EK, Kim HS, Kim BI, Choi JH
(2014) Rosiglitazone, a peroxisome proliferator-activated receptor-
gamma agonist, restores alveolar and pulmonary vascular develop-
ment in a rat model of bronchopulmonary dysplasia. Yonsei Med J
55:99–106
Lewis KJ, Tibbitt MW, Zhao Y, Branchfield K, Sun X, Balasubramaniam
V, Anseth KS (2015) In vitro model alveoli from photodegradable
microsphere templates. Biomater Sci 3:821–832
Liao J, Kapadia VS, Brown LS, Cheong N, Longoria C, Mija D,
Ramgopal M, Mirpuri J, McCurnin DC, Savani RC (2015) The
NLRP3 inflammasome is critically involved in the development of
bronchopulmonary dysplasia. Nat Commun 6:8977
Madurga A, Mižíková I, Ruiz-Camp J, Morty RE (2013) Recent ad-
vances in late lung development and the pathogenesis of
bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol
Physiol 305:L893–L905
Madurga A, Mižíková I, Ruiz-Camp J, Vadász I, Herold S, Mayer K,
Fehrenbach H, Seeger W, Morty RE (2014) Systemic hydrogen
sulfide administration partially restores normal alveolarization in
an experimental animal model of bronchopulmonary dysplasia.
Am J Physiol Lung Cell Mol Physiol 306:L684–L697
Madurga A, Golec A, Pozarska A, Ishii I, Mižíková I, Nardiello C,
Vadasz I, Herold S, Mayer K, Reichenberger F, Fehrenbach H,
Seeger W, Morty RE (2015) The H2S-generating enzymes cystathi-
onine beta-synthase and cystathionine gamma-lyase play a role in
vascular development during normal lung alveolarization. Am J
Physiol Lung Cell Mol Physiol 309:L710–L724
Maniscalco WM, Watkins RH, Pryhuber GS, Bhatt A, Shea C, Huyck H
(2002) Angiogenic factors and alveolar vasculature: development
and alterations by injury in very premature baboons. Am J Physiol
Lung Cell Mol Physiol 282:L811–L823
Manzano RM, Mascaretti RS, Carrer V, Haddad LB, Fernandes AR,
Reyes AM, Rebello CM (2014) A hyperoxic lung injury model in
premature rabbits: the influence of different gestational ages and
oxygen concentrations. PLoS One 9: e95844
Martin CR, ZamanMM, Gilkey C, Salguero MV, Hasturk H, Kantarci A,
Van Dyke TE, Freedman SD (2014) Resolvin D1 and lipoxin A4
improve alveolarization and normalize septal wall thickness in a
neonatal murine model of hyperoxia-induced lung injury. PLoS
One 9:e98773
Martin RJ, Fanaroff AA (2013) The preterm lung and airway: past, pres-
ent, and future. Pediatr Neonatol 54:228–234
466 Cell Tissue Res (2017) 367:457–468
MasoodA, YiM, LauM, Belcastro R, Li J, Kantores C, Pace-Asciak CR,
Jankov RP, Tanswell AK (2014) Cyclooxygenase-2 inhibition par-
tially protects against 60% O2-mediated lung injury in neonatal rats.
Pediatr Pulmonol 49:991–1002
McGowan SE, McCoy DM (2015) Fibroblast growth factor signaling in
myofibroblasts differs from lipofibroblasts during alveolar septation
in mice. Am J Physiol Lung Cell Mol Physiol 309:L463–L474
McKenna S, Michaelis KA, Agboke F, Liu T, Han K, Yang G, Dennery
PA, Wright CJ (2014) Sustained hyperoxia-induced NF-kappaB ac-
tivation improves survival and preserves lung development in neo-
natal mice. Am J Physiol Lung Cell Mol Physiol 306:L1078–L1089
Miranda LF, Rodrigues CO, Ramachandran S, Torres E, Huang J, Klim J,
Hehre D, McNiece I, Hare JM, Suguihara CY, Young KC (2013)
Stem cell factor improves lung recovery in rats following neonatal
hyperoxia-induced lung injury. Pediatr Res 74:682–688
Mižíková I, Ruiz-Camp J, Steenbock H, Madurga A, Vadász I, Herold S,
Mayer K, Seeger W, Brinckmann J, Morty RE (2015) Collagen and
elastin cross-linking is altered during aberrant late lung development
associated with hyperoxia. Am J Physiol Lung Cell Mol Physiol
308:L1145–L1158
MonzD, Tutdibi E,Mildau C, Shen J, KasohaM, LaschkeMW,Roolfs T,
Schmiedl A, Tschernig T, Bieback K, Gortner L (2013) Human
umbilical cord blood mononuclear cells in a double-hit model of
bronchopulmonary dysplasia in neonatal mice. PLoS One 8:e74740
Morrisey EE, Hogan BL (2010) Preparing for the first breath: genetic and
cellular mechanisms in lung development. Dev Cell 18:8–23
Morrisey EE, Cardoso WV, Lane RH, Rabinovitch M, Abman SH, Ai X,
Albertine KH, Bland RD, Chapman HA, Checkley W, Epstein JA,
Kintner CR, Kumar M, Minoo P, Mariani TJ, McDonald DM,
Mukouyama YS, Prince LS, Reese J, Rossant J, Shi W, Sun X,
Werb Z, Whitsett JA, Gail D, Blaisdell CJ, Lin QS (2013)
Molecular determinants of lung development. Ann Am Thorac
Soc 10:S12–S16
Morty RE, Königshoff M, Eickelberg O (2009) Transforming growth
factor-beta signaling across ages: from distorted lung development
to chronic obstructive pulmonary disease. Proc Am Thorac Soc 6:
607–613
Mühlfeld C (2014) Quantitative morphology of the vascularisation of
organs: a stereological approach illustrated using the cardiac circu-
lation. Ann Anat 196:12–19
Mühlfeld C, Ochs M (2013) Quantitative microscopy of the lung: a
problem-based approach. Part 2. Stereological parameters and study
designs in various diseases of the respiratory tract. Am J Physiol
Lung Cell Mol Physiol 305:L205–L221
Nakanishi H, Sugiura T, Streisand JB, Lonning SM, Roberts JD Jr (2007)
TGF-beta-neutral izing antibodies improve pulmonary
alveologenesis and vasculogenesis in the injured newborn lung.
Am J Physiol Lung Cell Mol Physiol 293:L151–L161
Nardiello C, Morty RE (2016) MicroRNA in late lung development and
bronchopulmonary dysplasia: the need to demonstrate causality.
Mol Cell Pediatr 3:19
NorthwayWH Jr (1992) Bronchopulmonary dysplasia: twenty-five years
later. Pediatrics 89:969–973
Northway WH Jr, Rosan RC, Porter DY (1967) Pulmonary disease fol-
lowing respirator therapy of hyaline-membrane disease.
Bronchopulmonary dysplasia. N Engl J Med 276:357–368
Ntokou A, Klein F, Dontireddy D, Becker S, Bellusci S, RichardsonWD,
Szibor M, Braun T, Morty RE, Seeger W, Voswinckel R, Ahlbrecht
K (2015) Characterization of the platelet-derived growth factor
receptor-alpha-positive cell lineage during murine late lung devel-
opment. Am J Physiol Lung Cell Mol Physiol 309:L942–L958
Null DM, Alvord J, Leavitt W, Wint A, Dahl MJ, Presson AP, Lane RH,
DiGeronimo RJ, Yoder BA, Albertine KH (2014) High-frequency
nasal ventilation for 21 d maintains gas exchange with lower respi-
ratory pressures and promotes alveolarization in preterm lambs.
Pediatr Res 75:507–516
O’Reilly M, Thébaud B (2014) Animal models of bronchopulmonary
dysplasia. The term rat models. Am J Physiol Lung Cell Mol
Physiol 307:L948–L958
Ochs M, Mühlfeld C (2013) Quantitative microscopy of the lung: a
problem-based approach. Part 1. Basic principles of lung stereology.
Am J Physiol Lung Cell Mol Physiol 305:L15–L22
Olave N, Lal CV, Halloran B, Pandit K, Cuna AC, Faye-Petersen OM,
Kelly DR, Nicola T, Benos P, Kaminski N, Ambalavanan N (2015)
Regulation of alveolar septation by microRNA-489. Am J Physiol
Lung Cell Mol Physiol 310:L476–L487
Papin JF, Wolf RF, Kosanke SD, Jenkins JD, Moore SN, Anderson MP,
Welliver RC Sr (2013) Infant baboons infected with respiratory syn-
cytial virus develop clinical and pathological changes that parallel
those of human infants. Am J Physiol Lung Cell Mol Physiol 304:
L530–L539
Park HS, Park JW, Kim HJ, Choi CW, Lee HJ, Kim BI, Chun YS (2013)
Sildenafil alleviates bronchopulmonary dysplasia in neonatal rats by
activating the hypoxia-inducible factor signaling pathway. Am J
Respir Cell Mol Biol 48:105–113
Pham H, Vottier G, Pansiot J, Duong-Quy S, Bollen B, Dalous J, Gallego
J, Mercier JC, Dinh-Xuan AT, Bonnin P, Charriaut-Marlangue C,
Baud O (2014) Inhaled NO prevents hyperoxia-induced white mat-
ter damage in neonatal rats. Exp Neurol 252:114–123
Pieretti AC, Ahmed AM, Roberts JD Jr, Kelleher CM (2014) A novel
in vitro model to study alveologenesis. Am J Respir Cell Mol Biol
50:459–469
Poon AW, Ma EX, Vadivel A, Jung S, Khoja Z, Stephens L, Thébaud B,
Wintermark P (2016) Impact of bronchopulmonary dysplasia on
brain and retina. Biol Open 5:475–483
Popova AP, Bentley JK, Cui TX, Richardson MN, Linn MJ, Lei J, Chen
Q, Goldsmith AM, Pryhuber GS, Hershenson MB (2014) Reduced
platelet-derived growth factor receptor expression is a primary fea-
ture of human bronchopulmonary dysplasia. Am J Physiol Lung
Cell Mol Physiol 307:L231–L239
Quantius J, Schmoldt C, Vazquez-Armendariz AI, Becker C, El Agha E,
Wilhelm J, Morty RE, Vadasz I, Mayer K, Gattenloehner S, Fink L,
Matrosovich M, Li X, Seeger W, Lohmeyer J, Bellusci S, Herold S
(2016) Influenza virus infects epithelial stem/progenitor cells of the
distal lung: impact on Fgfr2b-driven epithelial repair. PLoS Pathog
12:e1005544
Raffay TM, Locy ML, Hill CL, Jindal NS, Rogers LK, Welty SE, Tipple
TE (2013) Neonatal hyperoxic exposure persistently alters lung
secretoglobins and annexin A1. Biomed Res Int 2013:408485
Ramachandran S, Suguihara C, Drummond S, Chatzistergos K, Klim J,
Torres E, Huang J, Hehre D, Rodrigues CO, McNiece IK, Hare JM,
Young KC (2015) Bone marrow-derived c-kit+ cells attenuate neo-
natal hyperoxia-induced lung injury. Cell Transplant 24:85–95
Ratner V, Sosunov SA, Niatsetskaya ZV, Utkina-Sosunova IV, Ten VS
(2013)Mechanical ventilation causes pulmonarymitochondrial dys-
function and delayed alveolarization in neonatal mice. Am J Respir
Cell Mol Biol 49:943–950
Rawlins EL (2011) The building blocks of mammalian lung develop-
ment. Dev Dyn 240:463–476
Richter J, Toelen J, Vanoirbeek J, Kakigano A, Dekoninck P, Verbeken E,
Deprest J (2014) Functional assessment of hyperoxia-induced lung
injury after preterm birth in the rabbit. Am J Physiol Lung Cell Mol
Physiol 306:L277–L283
Rieger-Fackeldey E, Park MS, Schanbacher BL, Joshi MS, Chicoine LG,
Nelin LD, Bauer JA, Welty SE, Smith CV (2014) Lung develop-
ment alterations in newborn mice after recovery from exposure to
sublethal hyperoxia. Am J Pathol 184:1010–1016
Ruiz-Camp J, Morty RE (2015) Divergent fibroblast growth factor sig-
naling pathways in lung fibroblast subsets: where do we go from
here? Am J Physiol Lung Cell Mol Physiol 309:L751–L755
Sakurai R, Villarreal P, Husain S, Liu J, Sakurai T, Tou E, Torday JS,
Rehan VK (2013) Curcumin protects the developing lung against
Cell Tissue Res (2017) 367:457–468 467
long-term hyperoxic injury. Am J Physiol Lung Cell Mol Physiol
305:L301–L311
Salaets T, Richter J, Brady P, Jimenez J, Nagatomo T, Deprest J, Toelen J
(2015) Transcriptome analysis of the preterm rabbit lung after seven
days of hyperoxic exposure. PLoS One 10:e0136569
Schneider JP, Ochs M (2013) Stereology of the lung. Methods Cell Biol
113:257–294
Schneider JP, Ochs M (2014) Alterations of mouse lung tissue dimen-
sions during processing for morphometry: a comparison ofmethods.
Am J Physiol Lung Cell Mol Physiol 306:L341–L350
Silva DM, Nardiello C, PozarskaA,Morty RE (2015) Recent advances in
the mechanisms of lung alveolarization and the pathogenesis of
bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol
Physiol 309:L1239–L1272
Sluiter I, Veenma D, van Loenhout R, Rottier R, de Klein A, Keijzer R,
Post M, Tibboel D (2012) Etiological and pathogenic factors in
congenital diaphragmatic hernia. Eur J Pediatr Surg 22:345–354
Stoll BJ, HansenNI, Bell EF, Shankaran S, Laptook AR,WalshMC, Hale
EC, Newman NS, Schibler K, Carlo WA, Kennedy KA, Poindexter
BB, Finer NN, Ehrenkranz RA, Duara S, Sanchez PJ, O’Shea TM,
Goldberg RN, Van Meurs KP, Faix RG, Phelps DL, Frantz ID 3rd,
Watterberg KL, Saha S, Das A, Higgins RD, Eunice Kennedy
Shriver National Institute of Child H, Human Development
Neonatal Research N (2010) Neonatal outcomes of extremely pre-
term infants from the NICHD Neonatal Research Network.
Pediatrics 126:443–456
Sureshbabu A, Syed MA, Boddupalli CS, Dhodapkar MV, Homer RJ,
Minoo P, Bhandari V (2015) Conditional overexpression of
TGFbeta1 promotes pulmonary inflammation, apoptosis and mor-
tality via TGFbetaR2 in the developingmouse lung. Respir Res 16:4
Sutsko RP, Young KC, Ribeiro A, Torres E, Rodriguez M, Hehre D,
Devia C, McNiece I, Suguihara C (2013) Long-term reparative ef-
fects of mesenchymal stem cell therapy following neonatal
hyperoxia-induced lung injury. Pediatr Res 73:46–53
Syed MA, Bhandari V (2013) Hyperoxia exacerbates postnatal
inflammation-induced lung injury in neonatal BRP-39 null mutant
mice promoting theM1macrophage phenotype.Mediators Inflamm
2013:457189
Tibboel J, Joza S, Reiss I, de Jongste JC, Post M (2013) Amelioration of
hyperoxia-induced lung injury using a sphingolipid-based interven-
tion. Eur Respir J 42:776–784
Tibboel J, Groenman FA, Selvaratnam J, Wang J, Tseu I, Huang Z,
Caniggia I, Luo D, van Tuyl M, Ackerley C, de Jongste JC,
Tibboel D, Post M (2015) Hypoxia-inducible factor-1 stimulates
postnatal lung development but does not prevent O2-induced alve-
olar injury. Am J Respir Cell Mol Biol 52:448–458
Tschanz S, Schneider JP, Knudsen L (2014a) Design-based stereology:
planning, volumetry and sampling are crucial steps for a successful
study. Ann Anat 196:3–11
Tschanz SA, Salm LA, Roth-Kleiner M, Barre SF, Burri PH, Schittny JC
(2014b) Rat lungs show a biphasic formation of new alveoli during
postnatal development. J Appl Physiol 117:89–95
Ueda K, Cho K, Matsuda T, Okajima S, Uchida M, Kobayashi Y,
Minakami H, Kobayashi K (2006) A rat model for arrest of
alveolarization induced by antenatal endotoxin administration.
Pediatr Res 59:396–400
Vadivel A, Alphonse RS, Etches N, van Haaften T, Collins JJ, O’Reilly
M, Eaton F, Thébaud B (2014) Hypoxia-inducible factors promote
alveolar development and regeneration. Am J Respir Cell Mol Biol
50:96–105
Veenma DC, de Klein A, Tibboel D (2012) Developmental and genetic
aspects of congenital diaphragmatic hernia. Pediatr Pulmonol 47:
534–545
Wagenaar GT, el Laghmani H, de Visser YP, Sengers RM, Steendijk P,
Baelde HJ, Walther FJ (2013a) Ambrisentan reduces pulmonary
arterial hypertension but does not stimulate alveolar and vascular
development in neonatal rats with hyperoxic lung injury. Am J
Physiol Lung Cell Mol Physiol 304:L264–L275
Wagenaar GT, el Laghmani H, Fidder M, Sengers RM, de Visser
YP, de Vries L, Rink R, Roks AJ, Folkerts G, Walther FJ
(2013b) Agonists of MAS oncogene and angiotensin II type 2
receptors attenuate cardiopulmonary disease in rats with neo-
natal hyperoxia-induced lung injury. Am J Physiol Lung Cell
Mol Physiol 305:L341–L351
Wang H, Jafri A, Martin RJ, Nnanabu J, Farver C, Prakash YS,
MacFarlane PM (2014) Severity of neonatal hyperoxia determines
structural and functional changes in developing mouse airway. Am J
Physiol Lung Cell Mol Physiol 307:L295–L301
Warburton D, Bellusci S, De Langhe S, Del Moral PM, Fleury V,
Mailleux A, Tefft D, Unbekandt M, Wang K, Shi W (2005)
Molecular mechanisms of early lung specification and branching
morphogenesis. Pediatr Res 57:26R–37R
Warburton D, El-Hashash A, Carraro G, Tiozzo C, Sala F, Rogers O, De
Langhe S, Kemp PJ, Riccardi D, Torday J, Bellusci S, Shi W,
Lubkin SR, Jesudason E (2010) Lung organogenesis. Curr Top
Dev Biol 90:73–158
Weichelt U, Cay R, Schmitz T, Strauss E, Sifringer M, Buhrer C,
Endesfelder S (2013) Prevention of hyperoxia-mediated pulmonary
inflammation in neonatal rats by caffeine. Eur Respir J 41:966–973
West JB (2013) Marcello Malpighi and the discovery of the pulmonary
capillaries and alveoli. Am J Physiol Lung Cell Mol Physiol 304:
L383–L390
Whitehead GS, Burch LH, Berman KG, Piantadosi CA, Schwartz DA
(2006) Genetic basis of murine responses to hyperoxia-induced lung
injury. Immunogenetics 58:793–804
Willführ A, Brandenberger C, Piatkowski T, Grothausmann R,
Nyengaard JR, Ochs M, Mühlfeld C (2015) Estimation of the
number of alveolar capillaries by the Euler number (Euler-
Poincare characteristic). Am J Physiol Lung Cell Mol Physiol
309:L1286–L1293
Witsch TJ, Niess G, Sakkas E, Likhoshvay T, Becker S, Herold S, Mayer
K, Vadász I, Roberts JD Jr, Seeger W, Morty RE (2014a)
Transglutaminase 2: a new player in bronchopulmonary dysplasia?
Eur Respir J 44:109–121
Witsch TJ, Turowski P, Sakkas E, Niess G, Becker S, Herold S, Mayer K,
Vadász I, Roberts JD Jr, Seeger W, Morty RE (2014b) Deregulation
of the lysyl hydroxylasematrix cross-linking system in experimental
and clinical bronchopulmonary dysplasia. Am J Physiol Lung Cell
Mol Physiol 306:L246–L259
Wong PM, Lees AN, Louw J, Lee FY, French N, Gain K, Murray CP,
Wilson A, Chambers DC (2008) Emphysema in young adult survi-
vors of moderate-to-severe bronchopulmonary dysplasia. Eur
Respir J 32:321–328
Yoder BA, Coalson JJ (2014) Animal models of bronchopulmonary dys-
plasia. The preterm baboon models. Am J Physiol Lung Cell Mol
Physiol 307:L970–L977
Yoo HS, Chang YS, Kim JK, Ahn SY, Kim ES, Sung DK, Jeon GW,
Hwang JH, Shim JW, Park WS (2013) Antenatal betamethasone
attenuates intrauterine infection-aggravated hyperoxia-induced lung
injury in neonatal rats. Pediatr Res 73:726–733
Zürcher NR, Rodriguez JS, Jenkins SL, Keenan K, Bartlett TQ,
McDonald TJ, Nathanielsz PW, Nijland MJ (2010) Performance of
juvenile baboons on neuropsychological tests assessing associative
learning, motivation and attention. J Neurosci Methods 188:219–
225
468 Cell Tissue Res (2017) 367:457–468
